NASDAQ:MGTX MeiraGTx (MGTX) Stock Price, News & Analysis $11.16 +0.25 (+2.29%) As of 03:30 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About MeiraGTx Stock (NASDAQ:MGTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get MeiraGTx alerts:Sign Up Key Stats Today's Range$10.59▼$11.2750-Day Range$10.91▼$14.9752-Week Range$6.62▼$15.35Volume524,534 shsAverage Volume737,295 shsMarket Capitalization$1.07 billionP/E Ratio15.71Dividend YieldN/APrice Target$24.71Consensus RatingModerate Buy Company Overview MeiraGTx Holdings plc is a clinical-stage biotechnology company focused on developing gene therapies for serious diseases with limited treatment options. The company uses adeno-associated virus (AAV) vectors and other genetic medicine technologies to deliver therapeutic genes to targeted tissues, with an emphasis on disorders affecting the central nervous system, the eye and other organs. MeiraGTx’s pipeline has included botaretigene sparoparvovec, an investigational AAV-based gene therapy for X-linked retinitis pigmentosa caused by mutations in the RPGR gene. The company has also pursued gene therapy programs for neurological and neurodegenerative conditions, including Parkinson’s disease, as well as additional rare and potentially serious diseases. Its research platform includes technologies designed to regulate gene expression, which may help control the timing and amount of therapeutic proteins produced after treatment. Founded in 2015, MeiraGTx operates internationally, with activities in the United States and the United Kingdom. The company has established research, development and manufacturing capabilities to support its gene therapy programs and has entered into collaborations with larger pharmaceutical companies, including Johnson & Johnson. Alexandria Forbes is a co-founder and has served as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More MeiraGTx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreMGTX MarketRank™: MeiraGTx scored higher than 75% of companies evaluated by MarketBeat, and ranked 162nd out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingMeiraGTx has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 1 strong buy rating, 5 buy ratings, 3 hold ratings, and no sell ratings.Upside PotentialMeiraGTx has a consensus price target of $24.71, representing about 126.7% upside from its current price of $10.90.Amount of Analyst CoverageMeiraGTx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about MeiraGTx's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for MeiraGTx are expected to decrease in the coming year, from $0.30 to ($2.01) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MeiraGTx is 15.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.80.Price to Earnings Ratio vs. SectorThe P/E ratio of MeiraGTx is 15.35, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.32.Read more about MeiraGTx's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.51% of the float of MeiraGTx has been sold short.Short Interest Ratio / Days to CoverMeiraGTx has a short interest ratio ("days to cover") of 6.08.Change versus previous monthShort interest in MeiraGTx has recently increased by 7.75%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMeiraGTx does not currently pay a dividend.Dividend GrowthMeiraGTx does not have a long track record of dividend growth. News and Social Media2.6 / 5News Sentiment0.23 News SentimentMeiraGTx has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for MeiraGTx this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for MGTX on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added MeiraGTx to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,969,233.00 in company stock.Percentage Held by Insiders7.40% of the stock of MeiraGTx is held by insiders.Percentage Held by Institutions67.48% of the stock of MeiraGTx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MeiraGTx's insider trading history. Receive MGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MeiraGTx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MGTX Stock News HeadlinesAnalyzing MeiraGTx (NASDAQ:MGTX) and GeoVax Labs (NASDAQ:GOVX)September 28 at 3:58 AM | americanbankingnews.comMeiraGTx (NASDAQ:MGTX) Research Coverage Started at The Goldman Sachs GroupSeptember 27 at 1:48 AM | americanbankingnews.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.September 28 at 1:00 AM | Base Camp Trading (Ad)MeiraGTx (NASDAQ:MGTX) Cut to "Hold" at Wall Street ZenSeptember 26 at 2:29 AM | americanbankingnews.comGoldman Sachs Initiates MeiraGTx at Neutral With $16 Price TargetSeptember 24, 2026 | marketscreener.comMMeiraGTx Holdings plc Announces Appointment of Alan M. Sebulsky to its Board of DirectorsSeptember 23, 2026 | marketscreener.comMMeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of DirectorsSeptember 23, 2026 | globenewswire.comMeiraGTx Holdings PLC MGTXSeptember 16, 2026 | morningstar.comMSee More Headlines MGTX Stock Analysis - Frequently Asked Questions How have MGTX shares performed this year? MeiraGTx's stock was trading at $7.95 at the beginning of 2026. Since then, MGTX stock has increased by 37.1% and is now trading at $10.90. How were MeiraGTx's earnings last quarter? MeiraGTx Holdings PLC (NASDAQ:MGTX) announced its earnings results on Thursday, August, 13th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of ($0.46) by $2.17. The firm earned $321.43 million during the quarter, compared to the consensus estimate of $0.70 million. MeiraGTx had a net margin of 19.87% and a trailing twelve-month return on equity of 283.85%. When did MeiraGTx IPO? MeiraGTx (MGTX) raised $75 million in an initial public offering (IPO) on Friday, June 8th 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, Barclays and Evercore ISI served as the underwriters for the IPO and Chardan was co-manager. Who are MeiraGTx's major shareholders? MeiraGTx's top institutional shareholders include Johnson & Johnson (7.17%), BlackRock Inc. (5.14%), Opaleye Management Inc. (3.70%) and Jupiter Topco LLC (0.51%). Insiders that own company stock include Perceptive Advisors Llc, Alexandria Forbes, Richard Giroux and Stuart Naylor. View institutional ownership trends. How do I buy shares of MeiraGTx? Shares of MGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MeiraGTx own? Based on aggregate information from My MarketBeat watchlists, some other companies that MeiraGTx investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Moderna (MRNA). Company Calendar Last Earnings8/13/2026Today9/28/2026Next Earnings (Estimated)11/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (15m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 MGTX's financial health is in the Green zone, according to TradeSmith. MGTX has been in this zone for over 15 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:MGTX CIK1735438 Webwww.meiragtx.com Phone(646) 860-7985FaxN/AEmployees393Year Founded2015Price Target and Rating Average Price Target for MeiraGTx$24.71 High Price Target$35.00 Low Price Target$16.00 Potential Upside/Downside+124.5%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.71 Trailing P/E Ratio15.52 Forward P/E Ratio36.69 P/E GrowthN/ANet Income-$114.20 million Net Margins19.87% Pretax Margin20.45% Return on Equity283.85% Return on Assets29.39% Debt Debt-to-Equity Ratio0.46 Current Ratio3.76 Quick Ratio3.76 Sales & Book Value Annual Sales$81.39 million Price / Sales12.99 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-157.26Miscellaneous Outstanding Shares96,040,000Free Float88,936,000Market Cap$1.06 billion OptionableOptionable Beta1.27 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:MGTX) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our Partners"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
